The Diversity of Encephalitogenic CD4+ T Cells in Multiple Sclerosis and Its Animal Models
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Diversity of Encephalitogenic CD4+ T Cells in Multiple Sclerosis and Its Animal Models
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 8, Issue 1, Pages 120
Publisher
MDPI AG
Online
2019-01-22
DOI
10.3390/jcm8010120
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention
- (2018) Jamie van Langelaar et al. BRAIN
- The value of oligoclonal bands in the multiple sclerosis diagnostic criteria
- (2018) Georgina Arrambide et al. BRAIN
- An IFNγ/CXCL2 regulatory pathway determines lesion localization during EAE
- (2018) Joshua S. Stoolman et al. Journal of Neuroinflammation
- Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells
- (2018) Bryan Ceronie et al. JOURNAL OF NEUROLOGY
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- B cells are capable of independently eliciting rapid reactivation of encephalitogenic CD4 T cells in a murine model of multiple sclerosis
- (2018) Chelsea R. Parker Harp et al. PLoS One
- Oligoclonal bands in multiple sclerosis; functional significance and therapeutic implications. Does the specificity matter?
- (2018) Gareth Pryce et al. Multiple Sclerosis and Related Disorders
- Multiple sclerosis - a review
- (2018) R. Dobson et al. EUROPEAN JOURNAL OF NEUROLOGY
- Identification of Cortical and Subcortical Correlates of Cognitive Performance in Multiple Sclerosis Using Voxel-Based Morphometry
- (2018) Jordi A. Matías-Guiu et al. Frontiers in Neurology
- Deciphering the Role of B Cells in Multiple Sclerosis—Towards Specific Targeting of Pathogenic Function
- (2017) Klaus Lehmann-Horn et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- GM-CSF Promotes Chronic Disability in Experimental Autoimmune Encephalomyelitis by Altering the Composition of Central Nervous System–Infiltrating Cells, but Is Dispensable for Disease Induction
- (2017) Patrick C. Duncker et al. JOURNAL OF IMMUNOLOGY
- Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis
- (2017) Jeffrey M. Gelfand et al. Neurotherapeutics
- Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis
- (2017) Dan Hu et al. Nature Communications
- Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis
- (2017) David Baker et al. EBioMedicine
- Multiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic Review
- (2016) Sharareh Eskandarieh et al. NEUROEPIDEMIOLOGY
- Increasing prevalence of multiple sclerosis in Buenos Aires, Argentina
- (2016) E. Cristiano et al. Multiple Sclerosis and Related Disorders
- IL-12-polarized Th1 cells produce GM-CSF and induce EAE independent of IL-23
- (2015) Heather M. Grifka-Walk et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The immunogenetics of multiple sclerosis: A comprehensive review
- (2015) Jill A. Hollenbach et al. JOURNAL OF AUTOIMMUNITY
- Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
- (2015) Kevin S. Carbajal et al. JOURNAL OF IMMUNOLOGY
- Class II HLA interactions modulate genetic risk for multiple sclerosis
- (2015) Loukas Moutsianas et al. NATURE GENETICS
- Multiple Sclerosis Epidemiology in Middle East and North Africa: A Systematic Review and Meta-Analysis
- (2015) Pouria Heydarpour et al. NEUROEPIDEMIOLOGY
- Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2015) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Site-Specific Chemokine Expression Regulates Central Nervous System Inflammation and Determines Clinical Phenotype in Autoimmune Encephalomyelitis
- (2014) Joshua S. Stoolman et al. JOURNAL OF IMMUNOLOGY
- Stage-Specific Immune Dysregulation in Multiple Sclerosis
- (2014) Benjamin M. Segal JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS
- (2014) A. K. Huber et al. NEUROLOGY
- B-Cell Targeting Agents in the Treatment of Multiple Sclerosis
- (2013) Tiffany J. Braley et al. Current Treatment Options in Neurology
- T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease
- (2013) Richard A. O'Connor et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Highly polarized Th17 cells induce EAE via a T-bet independent mechanism
- (2013) Heather M. Grifka-Walk et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Diverting T helper cell trafficking through increased plasticity attenuates autoimmune encephalomyelitis
- (2013) Danielle Califano et al. JOURNAL OF CLINICAL INVESTIGATION
- Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial
- (2013) Ralf Gold et al. LANCET
- Meningeal and cortical grey matter pathology in multiple sclerosis
- (2012) Bogdan F Gh Popescu et al. BMC Neurology
- IL-23: One cytokine in control of autoimmunity
- (2012) Andrew L. Croxford et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci
- (2012) Eunyoung Lee et al. Journal of Neuroinflammation
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- IFN induces monopoiesis and inhibits neutrophil development during inflammation
- (2011) A. M. de Bruin et al. BLOOD
- Functional Specialization of Interleukin-17 Family Members
- (2011) Yoichiro Iwakura et al. IMMUNITY
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
- (2011) Stephen Sawcer et al. NATURE
- Fate mapping of IL-17-producing T cells in inflammatory responses
- (2011) Keiji Hirota et al. NATURE IMMUNOLOGY
- The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF
- (2011) Mohamed El-Behi et al. NATURE IMMUNOLOGY
- IL-23 modulated myelin-specific T cells induce EAE via an IFNγ driven, IL-17 independent pathway
- (2010) Mark A. Kroenke et al. BRAIN BEHAVIOR AND IMMUNITY
- EAE mediated by a non-IFN-γ/non-IL-17 pathway
- (2010) Mark A. Kroenke et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
- (2010) Robert C Axtell et al. NATURE MEDICINE
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preferential recruitment of interferon-γ-expressing TH17 cells in multiple sclerosis
- (2009) Hania Kebir et al. ANNALS OF NEUROLOGY
- B cell characterization and reactivity analysis in multiple sclerosis
- (2009) J. Fraussen et al. AUTOIMMUNITY REVIEWS
- Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological Phenotypes
- (2009) A. Jager et al. JOURNAL OF IMMUNOLOGY
- IL2RA Genetic Heterogeneity in Multiple Sclerosis and Type 1 Diabetes Susceptibility and Soluble Interleukin-2 Receptor Production
- (2009) Lisa M. Maier et al. PLoS Genetics
- T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis
- (2008) Chris J. Hedegaard et al. IMMUNOLOGY
- IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice
- (2008) Stefan Haak et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition
- (2008) Mark A. Kroenke et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Regional CNS responses to IFN-γ determine lesion localization patterns during EAE pathogenesis
- (2008) Jason R. Lees et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9–producing subset
- (2008) Marc Veldhoen et al. NATURE IMMUNOLOGY
- Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells
- (2008) Ingunn M Stromnes et al. NATURE MEDICINE
- Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
- (2007) John S. Tzartos et al. AMERICAN JOURNAL OF PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started